Cohn-Cedermark, G <br/><br/>
Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.  [electronic resource] 

 -  Andrology  Jan 2015 
 - 102-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2047-2927 
<br/><br/><label>Standard No.: </label>10.1111/andr.280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Chemotherapy, Adjuvant<br/>Disease Progression<br/>Disease-Free Survival<br/>Humans<br/>Male<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Neoplasms, Germ Cell and Embryonal--mortality<br/>Norway--epidemiology<br/>Patient Selection<br/>Predictive Value of Tests<br/>Risk Assessment<br/>Risk Factors<br/>Sweden--epidemiology<br/>Testicular Neoplasms--mortality<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Burden<br/>Watchful Waiting